本文選題：惡性潛能未定型子宮平滑肌腫瘤　切入點(diǎn)：STUMP　出處：《中國(guó)婦產(chǎn)科臨床雜志》2017年01期 　論文類型：期刊論文

【摘要】：目的 探討不同手術(shù)方法治療梭型細(xì)胞分化的惡性潛能未定型子宮平滑肌腫瘤的術(shù)后復(fù)發(fā)情況。方法 選取2009年1月1日至2015年12月30日期間在中國(guó)人民解放軍陸軍總醫(yī)院婦科接受手術(shù)治療,經(jīng)病理科醫(yī)師采用同一診斷標(biāo)準(zhǔn)對(duì)手術(shù)切片再次復(fù)核后證實(shí)患有梭型細(xì)胞分化的惡性潛能未定型子宮平滑肌腫瘤的患者。通過搜集臨床資料及術(shù)后隨訪,比較不同手術(shù)方式和途徑對(duì)術(shù)后復(fù)發(fā)率的影響。結(jié)果 搜集到23位患者,隨訪時(shí)間2.5~69個(gè)月,2例(1例行經(jīng)腹子宮腫物切除術(shù)治療,1例行腹腔鏡下子宮腫物切除術(shù)治療)于術(shù)后復(fù)發(fā)。將子宮腫物切除術(shù)組和全子宮切除術(shù)組以及經(jīng)腹手術(shù)組和腔鏡手術(shù)組進(jìn)行Fisher確切概率檢驗(yàn),雙側(cè)檢驗(yàn)P值均大于0.05。結(jié)論 尚不能認(rèn)為采用不同手術(shù)方法(全子宮切除術(shù)、子宮腫物切除術(shù))及手術(shù)途徑(經(jīng)腹、腔鏡手術(shù))治療該腫瘤在術(shù)后復(fù)發(fā)率方面有顯著差異,但仍需通過擴(kuò)大樣本量進(jìn)一步證實(shí)。
[Abstract]:Objective to investigate the recurrence of malignant potential uterine smooth muscle tumors with spindle cell differentiation treated by different surgical methods. Methods from January 1st 2009 to December 30th 2015, we selected from the Chinese people's Liberation Army from January 1st 2009 to December 30th 2015 to study the recurrence of uterine smooth muscle tumors. General Army Hospital Gynecology received surgical treatment, By using the same diagnostic criteria, pathologists confirmed the patients with malignant potential uterine smooth muscle tumors with fusiform cell differentiation after reexamination of surgical sections. Clinical data were collected and followed up after operation. The effects of different surgical methods and approaches on the postoperative recurrence rate were compared. Results 23 patients were collected. Two cases were followed up for 2.5 ~ 69 months. One patient underwent abdominal hysterectomy and one patient underwent laparoscopic hysterectomy. The hysterectomy group, the total hysterectomy group and the transabdominal operation group were treated with hysterectomy and total hysterectomy. The exact probability test of Fisher was performed in the endoscopic group. The P values of bilateral tests were all greater than 0.05. Conclusion there is significant difference in the recurrence rate of the tumor treated by different surgical methods (total hysterectomy, hysterectomy) and operative methods (transabdominal, endoscopic surgery). However, it still needs to be further confirmed by expanding the sample size.
【作者單位】： 大連醫(yī)科大學(xué)中國(guó)人民解放軍陸軍總醫(yī)院臨床學(xué)院;北京市房山區(qū)婦幼保健院;安徽醫(yī)科大學(xué)陸軍總醫(yī)院臨床學(xué)院;中國(guó)人民解放軍陸軍總醫(yī)院;

【相似文獻(xiàn)】

相關(guān)會(huì)議論文 前2條

1 余永偉;朱焱;;腎上皮樣血管平滑肌脂肪瘤臨床病理及分子生物學(xué)觀察[A];中華醫(yī)學(xué)會(huì)病理學(xué)分會(huì)2010年學(xué)術(shù)年會(huì)日程及論文匯編[C];2010年

2 高磊;唐達(dá)星;李民駒;徐珊;顧偉忠;何瑾;陳中宇;;小兒膀胱低度惡性潛能乳頭上皮腫瘤1例報(bào)道[A];2013年浙江省醫(yī)學(xué)會(huì)小兒外科學(xué)學(xué)術(shù)年會(huì)暨分會(huì)成立30周年慶典論文匯編[C];2013年

，

本文編號(hào)：1558534